{{Rsnum
|rsid=3780901
|Gene=ALOX5
|Chromosome=10
|position=45917376
|Orientation=plus
|GMAF=0.3214
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.2 | 48.7 | 37.2
| HCB | 8.0 | 33.6 | 58.4
| JPT | 7.1 | 39.8 | 53.1
| YRI | 20.4 | 51.7 | 27.9
| ASW | 22.8 | 38.6 | 38.6
| CHB | 8.0 | 33.6 | 58.4
| CHD | 4.6 | 28.7 | 66.7
| GIH | 25.7 | 49.5 | 24.8
| LWK | 13.6 | 56.4 | 30.0
| MEX | 10.3 | 37.9 | 51.7
| MKK | 26.3 | 48.7 | 25.0
| TSI | 13.7 | 49.0 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=21187935
|Title=Genes Involved in the Metabolism of Poly-Unsaturated Fatty-Acids (PUFA) and Risk for Crohn's Disease in Children &amp; Young Adults
|OA=1
}}

{{PMID|17909879|OA=1
}} Association studies of ALOX5 and bone mineral density in healthy adults.

{{PMID|18366797|OA=1
}} Influence of leukotriene gene polymorphisms on chronic rhinosinusitis.

{{PMID|20592751|OA=1
}} Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}